Let's break down Cipla Ltd. (CIPLA) — from its financial performance to how the market is valuing the stock.
Cipla Revenue Trend
Year-over-year, Cipla Ltd. grew revenue by 7.1% — from ₹26,521 Cr in FY2024 to ₹28,409 Cr in FY2025.
A 9.6% CAGR over 10 years is middle-of-the-road. Cipla Ltd.'s top line moved from ₹11,345 Cr to ₹28,409 Cr in that period.
A ₹28,409 Cr revenue base makes Cipla Ltd. a major name in the Indian pharmaceuticals sector.
Cipla Ltd. has posted revenue growth for 10 consecutive years — that's a sustained trend, not a one-off.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹28,409 Cr | +7.1% |
| FY2024 | ₹26,521 Cr | +16.6% |
| FY2023 | ₹22,753 Cr | +4.5% |
| FY2022 | ₹21,763 Cr | +13.6% |
| FY2021 | ₹19,160 Cr | — |
View Cipla Ltd.'s full 10-year revenue trend with CAGR analysis →
Cipla Profitability
Year-over-year, net profit grew 26.9% from ₹4,154 Cr to ₹5,269 Cr in FY2025 for Cipla Ltd..
A stronger net margin of 18.5% in FY2025 (from 15.7%) points to better profitability per rupee of revenue.
Diluted EPS came in at ₹65.24 for FY2025, up from ₹51.01 a year earlier.
Is Cipla Undervalued
Based on the P/E Ratio model, Cipla Ltd.'s fair value works out to ₹1,967 — 43.0% upside from where it trades today.
Cipla Ltd. shares are currently trading at ₹1,375.20.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹1,967 | 43.0% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Cipla Ltd. with detailed assumptions →
Cipla Shareholding Pattern
Promoter holding is steady at 29.2% — no buying or selling over the past 4 quarters.
Foreign investors held 23.9% of the company as of December 2025, down year-over-year from 26.3%.
Domestic institutions moved their stake up to 30.7% from 28.1% over the past year.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Dec 2025 | 29.2% | 23.9% | 30.7% | 16.1% |
| Sep 2025 | 29.2% | 24.6% | 30.2% | 16.0% |
| Jun 2025 | 29.2% | 25.2% | 29.3% | 16.3% |
| Mar 2025 | 29.2% | 26.3% | 28.1% | 16.4% |
Track quarterly shareholding changes for Cipla Ltd. →
Cipla Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2025 total assets: ₹373.87B (up 14.3% YoY from ₹327.18B).
Top categories: Cash & ST Investments (21.1%), Other Assets (17.6%), Property, Plant & Equipment (16.1%).
Of the ₹373.87B in liabilities and equity, 83.7% is shareholder equity, 1.2% is interest-bearing debt, and 15.1% is operating liabilities. Over the year, debt is down 21.7% and equity is up 16.7%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 78.82B |
| Receivables | 55.06B |
| Inventories | 56.42B |
| Property, Plant & Equipment | 60.27B |
| Investments | 7.51B |
| Intangibles & Goodwill | 49.86B |
| Other Assets | 65.93B |
| Category | Value |
|---|---|
| Equity | 312.89B |
| Short-term Debt | 1.86B |
| Long-term Debt | 2.52B |
| Trade Payables | 28.37B |
| Other Liabilities | 28.22B |
What Stands Out About Cipla
In summary, Cipla Ltd. (CIPLA) presents the following picture for fundamental analysts.
Revenue of ₹28,409 Cr in FY2025, up 7.1% year-over-year.
Long-term revenue has been compounding at 9.6% annually over 10 years.
The company is profitable, with a net margin of 18.5% and net income of ₹5,269 Cr.
The P/E Ratio model implies 43.0% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Cipla Ltd.'s detailed profile on Craytheon.